"The Global Clinical Trials Ecosystem: A Critical Evaluation and Future" by Sydney-Ariel D. Muneses

Date of Award

Spring 5-19-2025

Document Type

Undergraduate Honors Thesis

Degree Name

Bachelor of Business Administration in International Business

Department

International Business

Advisor

Eileen Daspro, DBA

Abstract

As global clinical trials expand, inconsistencies in regulatory and ethical frameworks are increasingly evident, raising concerns about economic sustainability and participant protections. Existing research attributes this surge to pharmaceutical companies seeking cost efficiencies in emerging markets but acknowledges the challenges posed by fragmented oversight across international jurisdictions. To examine these limitations, a modified Delphi approach was used to gather expert insights from key stakeholders in global clinical trials. Findings highlighted systemic inefficiencies and ethical gaps, emphasizing the need for regulatory harmonization to balance scientific rigor, economic feasibility, and equitable participant treatment. By identifying critical shortcomings and proposing strategies to align global practices, the research contributed to ongoing efforts to strengthen the integrity and sustainability of multinational clinical trials.

Share

COinS